(Q44675478)

English

A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

retracted paper

1 reference

Retraction Watch

9 February 2024

https://doi.org/10.1007/s00404-023-07330-z

A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

0 references

author name string

Mohammad Ebrahim Parsanezhad

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Saeed Alborzi

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Bahia Namavar Jahromi

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

24 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Archives of Gynecology and Obstetrics

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

269

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

125-129

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

https://scigraph.springernature.com/pub.10.1007/s00404-002-0437-x

0 references

A rationale for the use of bromocriptine in patients with amenorrhea and normoprolactinemia

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

Pituitary Tumors Associated with Hyperprolactinemia and Polycystic Ovarian Disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

Effect of bromocriptine on LH pulsatility in the polycystic ovary syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

Treatment of chronic anovulation resistant to clomiphene citrate (CC) by using oral contraceptive ovarian suppression followed by repeat CC treatment

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

Aggravation of inappropriate luteinizing hormone secretion by bromocriptine in polycystic ovary syndrome with elevated serum dehydroepiandrosterone sulfate

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

The effect of bromocriptine in the polycystic ovary syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

Exaggerated prolactin response of thyrotropin-releasing hormone in women with anovulatory cycles: possible role of endogenous estrogens and effect of bromocriptine

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S00404-002-0437-X

Identifiers

10.1007/S00404-002-0437-X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44675478&oldid=2073794071"